Hunutlu, F.Ç.; Öztop, H.; Gürsoy, V.; Ersal, T.; Elgün, E.; Yavuz, Ş.; İldemir Ekizoğlu, S.; Ekizoğlu, A.A.; Özkocaman, V.; Özkalemkaş, F.
Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy. Diagnostics 2025, 15, 185.
https://doi.org/10.3390/diagnostics15020185
AMA Style
Hunutlu FÇ, Öztop H, Gürsoy V, Ersal T, Elgün E, Yavuz Ş, İldemir Ekizoğlu S, Ekizoğlu AA, Özkocaman V, Özkalemkaş F.
Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy. Diagnostics. 2025; 15(2):185.
https://doi.org/10.3390/diagnostics15020185
Chicago/Turabian Style
Hunutlu, Fazıl Çağrı, Hikmet Öztop, Vildan Gürsoy, Tuba Ersal, Ezel Elgün, Şeyma Yavuz, Selin İldemir Ekizoğlu, Azim Ali Ekizoğlu, Vildan Özkocaman, and Fahir Özkalemkaş.
2025. "Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy" Diagnostics 15, no. 2: 185.
https://doi.org/10.3390/diagnostics15020185
APA Style
Hunutlu, F. Ç., Öztop, H., Gürsoy, V., Ersal, T., Elgün, E., Yavuz, Ş., İldemir Ekizoğlu, S., Ekizoğlu, A. A., Özkocaman, V., & Özkalemkaş, F.
(2025). Modified Endothelial Activation and Stress Index: A New Predictor for Survival Outcomes in Classical Hodgkin Lymphoma Treated with Doxorubicin-Bleomycin-Vinblastine-Dacarbazine-Based Therapy. Diagnostics, 15(2), 185.
https://doi.org/10.3390/diagnostics15020185
